2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

被引：543

作者：

Hicks, Karen A. ^{[1
]}

Mahaffey, Kenneth W. ^{[2
]}

Mehran, Roxana ^{[3
]}

Nissen, Steven E. ^{[4
]}

Wiviott, Stephen D. ^{[5
]}

Dunn, Billy ^{[6
]}

Solomon, Scott D. ^{[7
]}

Marler, John R. ^{[6
]}

Teerlink, John R. ^{[8
,9
]}

Farb, Andrew ^{[10
]}

Morrow, David A. ^{[5
]}

Targum, Shari L. ^{[1
]}

Sila, Cathy A. ^{[11
]}

Hai, Mary T. Thanh ^{[12
]}

Jaff, Michael R. ^{[13
]}

Joffe, Hylton V. ^{[14
]}

Cutlip, Donald E. ^{[15
]}

Desai, Akshay S. ^{[7
]}

Lewis, Eldrin F. ^{[7
]}

Gibson, C. Michael ^{[16
]}

Landray, Martin J. ^{[17
,18
]}

Lincoff, A. Michael

White, Christopher J. ^{[19
]}

Brooks, Steven S. ^{[20
]}

Rosenfield, Kenneth ^{[21
]}

Domanski, Michael J. ^{[22
]}

Lansky, Alexandra J. ^{[23
]}

McMurray, John J. V. ^{[24
]}

Tcheng, James E. ^{[25
]}

Steinhubl, Steven R. ^{[26
]}

Burton, Paul ^{[27
]}

Mauri, Laura ^{[28
]}

O'Connor, Christopher M. ^{[29
]}

Pfeffer, Marc A.

Hung, H. M. James ^{[30
]}

Stockbridge, Norman L. ^{[1
]}

Chaitman, Bernard R. ^{[31
]}

Temple, Robert J. ^{[32
]}

机构：

[1] US FDA, Div Cardiovasc & Renal Prod, Off Drug Evaluat 1, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,Bldg 22,Room 4182, Silver Spring, MD 20993 USA

[2] Stanford Univ, Dept Med, Sch Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA

[3] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA

[4] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA

[5] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA

[6] US FDA, Div Neurol Prod, Off Drug Evaluat 1, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[7] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA

[8] Univ Calif San Francisco, Sect Cardiol, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA

[9] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA

[10] US FDA, Div Cardiovasc Devices, Ctr Devices & Radiol Hlth, Silver Spring, MD USA

[11] Univ Hosp Cleveland, Med Ctr, Neurol Inst, Cleveland, OH 44106 USA

[12] US FDA, Off Drug Evaluat 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[13] Harvard Med Sch, Dept Med, Boston, MA USA

[14] US FDA, Div Bone Reprod & Urol Prod, Off Drug Evaluat 3, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[15] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Cardiol Div, Boston, MA USA

[16] Harvard Med Sch, Dept Med, Cardiovasc Div, Boston, MA USA

[17] Univ Oxford, Clin Trial Serv Unit, Oxford, England

[18] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England

[19] Ochsner Clin Sch, Dept Cardiol, New Orleans, LA USA

[20] Brooks Medtech LLC, Reisterstown, MD USA

[21] Massachusetts Gen Hosp, Corrigan Minehan Heart Ctr, Vasc Med & Intervent, Boston, MA 02114 USA

[22] Univ Toronto, Peter Munk Cardiac Ctr, Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada

[23] Yale Sch Med, Cardiol Sect, Dept Internal Med, New Haven, CT USA

[24] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

[25] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC USA

[26] Scripps Translat Sci Inst, Div Digital Med, La Jolla, CA USA

[27] Janssen Pharmaceut Inc, Cardiovasc & Metab Med Affairs, Titusville, NJ USA

[28] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA USA

[29] Inova Heart & Vasc Inst, Div Cardiol, Falls Church, VA USA

[30] US FDA, Ctr Drug Evaluat & Res, Off Biostat, Div Biometr 1, Silver Spring, MD USA

[31] St Louis Univ, Sch Med, Ctr Comprehens Cardiovasc Care, St Louis, MO USA

[32] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 09期

基金：

美国国家卫生研究院;

关键词：

cardiovascular and stroke endpoint definitions; cardiovascular and stroke outcome definitions; cardiovascular and stroke outcomes; cardiovascular endpoint definitions; cardiovascular endpoints; cardiovascular outcomes; clinical trial endpoint definitions; clinical trial endpoints; endpoint definitions; endpoints; outcome definitions; stroke endpoint definitions; stroke endpoints; stroke outcomes; TRANSIENT ISCHEMIC ATTACK; HEALTH-CARE PROFESSIONALS; CARDIAC TROPONIN-T; MYOCARDIAL-INFARCTION; HEART-FAILURE; CONSENSUS DOCUMENT; COMMITTEE; INTERVENTION; MORTALITY; STATEMENT;

D O I：

10.1016/j.jacc.2017.12.048

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the U.S. Food and Drug Administration (FDA). The FDA established the Standardized Data Collection for Cardiovascular Trials Initiative in 2009 to simplify the design and conduct of clinical trials intended to support marketing applications. The writing committee recognizes that these definitions may be used in other types of clinical trials and clinical care processes where appropriate. Use of these definitions at the FDA has enhanced the ability to aggregate data within and across medical product development programs, conduct meta-analyses to evaluate cardiovascular safety, integrate data from multiple trials, and compare effectiveness of drugs and devices. Further study is needed to determine whether prospective data collection using these common definitions improves the design, conduct, and interpretability of the results of clinical trials. Published jointly by the American College of Cardiology Foundation and American Heart Association, Inc.

引用

页码：1021 / 1034

页数：14

共 29 条

[1]

Transient ischemic attack - Proposal for a new definition. [J].

Albers, GW ;

Caplan, LR ;

Easton, JD ;

Fayad, PB ;

Mohr, JP ;

Saver, JL ;

Sherman, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1713-1716

[2]

Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].

Alpert, JS ;

Antman, E ;

Apple, F ;

Armstrong, PW ;

Bassand, JP ;

de Luna, AB ;

Beller, G ;

Breithardt, G ;

Chaitman, BR ;

Clemmensen, P ;

Falk, E ;

Fishbein, MC ;

Galvani, M ;

Garson, A ;

Grines, C ;

Hamm, C ;

Jaffe, A ;

Katus, H ;

Kjekshus, J ;

Klein, W ;

Klootwijk, P ;

Lenfant, C ;

Levy, D ;

Levy, RI ;

Luepker, R ;

Marcus, F ;

Näslund, U ;

Ohman, M ;

Pahlm, O ;

Poole-Wilson, P ;

Popp, R ;

Alto, P ;

Pyörälä, K ;

Ravkilde, J ;

Rehnquist, N ;

Roberts, W ;

Roberts, R ;

Roelandt, J ;

Rydén, L ;

Sans, S ;

Simoons, ML ;

Thygesen, K ;

Tunstall-Pedoe, H ;

Underwood, R ;

Uretsky, BF ;

Van de Werf, F ;

Voipio-Pulkki, LM ;

Wagner, G ;

Wallentin, L ;

Wijns, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969

[3]

[Anonymous], 1979, Circulation, V59, P607

[4]

[Anonymous], 2007, J AM COLL CARDIOL, DOI [DOI 10.1016/J.JACC.2007.09.011, DOI 10.1016/j.jacc.2007.09.011]

[5]

[Anonymous], GUID IND DIAB MELL E

[6]

Unstable Angina: Is It Time for a Requiem? [J].

Braunwald, Eugene ;

Morrow, David A. .

CIRCULATION, 2013, 127 (24) :2452-2457

[7]

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [J].

Burgess, David C. ;

Hunt, David ;

Li, LiPing ;

Zannino, Diana ;

Williamson, Elizabeth ;

Davis, Timothy M. E. ;

Laakso, Markku ;

Kesaniemi, Y. Antero ;

Zhang, Jun ;

Sy, Raymond W. ;

Lehto, Seppo ;

Mann, Stewart ;

Keech, Anthony C. .

EUROPEAN HEART JOURNAL, 2010, 31 (01) :92-99

[8]

The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction [J].

Chaitman, Bernard R. ;

Hardison, Regina M. ;

Adler, Dale ;

Gebhart, Suzanne ;

Grogan, Mary ;

Ocampo, Salvador ;

Sopko, George ;

Ramires, Jose A. ;

Schneider, David ;

Frye, Robert L. .

CIRCULATION, 2009, 120 (25) :2529-U44

[9]

Clinical end points in coronary stent trials - A case for standardized definitions [J].

Cutlip, Donald E. ;

Windecker, Stephan ;

Mehran, Roxana ;

Boam, Ashley ;

Cohen, David J. ;

van Es, Gerrit-Anne ;

Steg, P. Gabriel ;

Morel, Marie-angele ;

Mauri, Laura ;

Vranckx, Pascal ;

McFadden, Eugene ;

Lansky, Alexandra ;

Hamon, Martial ;

Krucoff, Mitchell W. ;

Serruys, Patrick W. .

CIRCULATION, 2007, 115 (17) :2344-2351

[10]

Definition and Evaluation of Transient Ischemic Attack A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. [J].

Easton, J. Donald ;

Saver, Jeffrey L. ;

Albers, Gregory W. ;

Alberts, Mark J. ;

Chaturvedi, Seemant ;

Feldmann, Edward ;

Hatsukami, Thomas S. ;

Higashida, Randall T. ;

Johnston, S. Claiborne ;

Kidwell, Chelsea S. ;

Lutsep, Helmi L. ;

Miller, Elaine ;

Sacco, Ralph L. .

STROKE, 2009, 40 (06) :2276-2293

← 1 2 3 →